Alkermes Plc (ALKS)
44.44
+0.81
(+1.86%)
USD |
NASDAQ |
Oct 26, 16:00
44.46
+0.02
(+0.03%)
After-Hours: 20:00
Alkermes Price : 44.44 for Oct. 26, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 26, 2026 | 44.11 | 44.84 | 43.60 | 44.44 | 1.177M |
| Oct 23, 2026 | 44.15 | 44.15 | 43.15 | 43.63 | 884581.0 |
| Oct 22, 2026 | 44.00 | 44.69 | 43.00 | 44.18 | 1.834M |
| Oct 21, 2026 | 44.12 | 44.58 | 43.44 | 43.48 | 1.808M |
| Oct 20, 2026 | 43.38 | 45.20 | 43.20 | 44.11 | 2.202M |
| Oct 19, 2026 | 41.46 | 43.64 | 41.35 | 42.97 | 2.793M |
| Oct 16, 2026 | 40.18 | 41.57 | 39.71 | 41.22 | 3.408M |
| Oct 15, 2026 | 39.74 | 40.74 | 39.42 | 40.10 | 1.977M |
| Oct 14, 2026 | 39.59 | 40.65 | 38.98 | 39.08 | 1.551M |
| Oct 13, 2026 | 40.26 | 40.35 | 39.67 | 39.73 | 1.068M |
| Oct 12, 2026 | 40.67 | 40.87 | 40.00 | 40.26 | 2.240M |
| Oct 09, 2026 | 40.18 | 40.87 | 39.99 | 40.61 | 1.627M |
| Oct 08, 2026 | 41.10 | 41.26 | 39.10 | 40.11 | 3.251M |
| Oct 07, 2026 | 41.28 | 42.06 | 41.16 | 41.44 | 1.816M |
| Oct 06, 2026 | 42.64 | 42.71 | 41.24 | 41.65 | 1.546M |
| Oct 05, 2026 | 42.07 | 43.22 | 41.67 | 42.76 | 3.125M |
| Oct 02, 2026 | 41.03 | 41.96 | 40.32 | 41.75 | 2.423M |
| Oct 01, 2026 | 40.00 | 41.41 | 39.99 | 40.54 | 2.626M |
| Sep 30, 2026 | 40.94 | 40.94 | 39.92 | 40.52 | 2.527M |
| Sep 29, 2026 | 39.84 | 40.90 | 39.84 | 40.80 | 2.687M |
| Sep 28, 2026 | 40.71 | 40.97 | 40.04 | 40.15 | 2.356M |
| Sep 25, 2026 | 40.94 | 41.12 | 40.49 | 40.85 | 2.588M |
| Sep 24, 2026 | 42.55 | 42.55 | 40.59 | 40.79 | 2.843M |
| Sep 23, 2026 | 43.20 | 43.62 | 41.23 | 42.13 | 2.476M |
| Sep 22, 2026 | 44.39 | 44.53 | 43.08 | 43.29 | 2.311M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amarin Corp. Plc | 12.09 |
| Prothena Corp. Plc | 8.40 |
| Incyte Corp. | 113.31 |
| Cue Biopharma, Inc. | 18.45 |
| ADC Therapeutics SA | 1.51 |
Price Related Metrics
| PE Ratio | 115.43 |
| PS Ratio | 4.515 |
| Price to Book Value | 4.117 |
| Price to Free Cash Flow | 33.97 |
| Earnings Yield | 0.87% |
| Market Cap | 7.446B |
| Operating PE Ratio | 52.41 |
| Normalized PE Ratio | 90.40 |